Spherium Biomed announces clinical trial Cyclatop is safe and efficacious for Atopic Dermatitis

Spherium Biomed presented last Saturday at the EADV Congress in Paris the results of the clinical trial Cyclatop (NCT02865356) to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019 (Cyclosporine A 5% topical spray) across…

Comments Off on Spherium Biomed announces clinical trial Cyclatop is safe and efficacious for Atopic Dermatitis